Prudential Financial’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-35,349
| Closed | -$1.14M | – | 2742 |
|
2024
Q1 | $1.14M | Sell |
35,349
-25,381
| -42% | -$820K | ﹤0.01% | 1750 |
|
2023
Q4 | $2.56M | Buy |
60,730
+35,890
| +144% | +$1.51M | ﹤0.01% | 1284 |
|
2023
Q3 | $954K | Sell |
24,840
-48,400
| -66% | -$1.86M | ﹤0.01% | 1790 |
|
2023
Q2 | $1.39M | Sell |
73,240
-50,390
| -41% | -$956K | ﹤0.01% | 1633 |
|
2023
Q1 | $1.92M | Buy |
123,630
+6,900
| +6% | +$107K | ﹤0.01% | 1368 |
|
2022
Q4 | $2.07M | Buy |
116,730
+350
| +0.3% | +$6.21K | ﹤0.01% | 1290 |
|
2022
Q3 | $650K | Buy |
+116,380
| New | +$650K | ﹤0.01% | 1953 |
|
2021
Q2 | – | Sell |
-18,114
| Closed | -$290K | – | 2591 |
|
2021
Q1 | $290K | Buy |
18,114
+13,436
| +287% | +$215K | ﹤0.01% | 2282 |
|
2020
Q4 | $217K | Buy |
+4,678
| New | +$217K | ﹤0.01% | 2338 |
|